CIK 0001566044
- Non-accelerated filer
- Smaller reporting company
Yarrow Bioscience, Inc.
Sign in to watch- Ticker
- YARW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453757789
- Phone
- +1 203-433-7577
- Business address
- 470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
- Former names
- VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 4,675 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 4,857 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF LEGAL OFFICER AND GC gave up 4,697 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 24,536 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award PRESIDENT AND CEO acquired 3,901 shares (grant or award)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 84 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 109 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 685 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF LEGAL OFFICER AND GC gave up 105 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 92 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 138 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF LEGAL OFFICER AND GC gave up 143 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 935 shares (to pay taxes)
- 4 Grant or award PRESIDENT AND CEO acquired 4,429 shares (grant or award)
Page 4 of 17 · 330 filings